biological source
mouse
conjugate
unconjugated
Quality Level
Gene Information
vaccinia virus ... ORF45(4961474)
antibody product type
primary antibodies
clone
ORF45, monoclonal
mol wt
calculated mol wt 43.33 kDa, observed mol wt ~70 kDa
purified by
using protein G
species reactivity
virus
packaging
antibody small pack of 100 μg
technique(s)
immunocytochemistry: suitable, immunoprecipitation (IP): suitable, western blot: suitable
isotype
IgG1κ
epitope sequence
Unknown
Protein ID accession no.
UniProt accession no.
shipped in
ambient
target post-translational modification
unmodified
General description
Human herpesvirus-8 (also known as Kaposi′s sarcoma-associated herpesvirus, HHV-8, KSHV) is etiologically associated with all forms of Kaposi sarcoma (KS) including classic, endemic, transplant-related, and AIDS-related, as well as rare neoplastic disorders. It is a double stranded DNA virus with a large genome that encodes for over 87 open reading frames (ORFs) including genes necessary for capsid, tegument, envelope, DNA replication and regulatory proteins. HHV-8 undergoes a bi-phasic lifecycle and can persist indefinitely in the infected host in a latent form during which time only a small fraction of regulatory viral proteins is expressed. ORF45 is an immediate-early phosphoprotein that localizes in the cytoplasm and acts as a viral lytic protein. It interacts with KIF3A, a subunit of kinesin-2 motor protein that transports cargoes along microtubules to cell periphery. The N-terminal amino acids 1-115 and C-terminal amino acids 332-407 of ORF45 are reported to interact with KIF3A. Inhibition of KIF3A-ORF45 interaction is shown to reduce HHV-8 maturation and egress. ORF45 also interacts with interferon regulatory factor 7 and inhibits virus-mediated interferon a/b induction. (Ref.: Sathish, N., et al. (2009). PLoS Pathog 5(3): e1000332; Zhu, FX., et al. (2005). J. Virol. 79(2);800-811; Zhu, FX., and Yuan, Y. (2003). J. Virol. 77(7); 4221-4230).
Immunogen
Baculovirus-synthesized ORF45 protein.
Application
Quality Control Testing
Evaluated by Western Blotting in TPA-induced BCBL-1 cell lysates.
Western Blotting Analysis (WB): A 1:1,000 dilution of this antibody detected HHV-8 (Kaposi′s sarcoma-associated herpesvirus) ORF45 protein in lysates from 12-O-Tetradecanoylphorbol-13-acetate (TPA; 20 ng/mL; 5-7 days)-induced BCBL-1 cells.
Tested Applications
Western Blotting Analysis: A representative lot detected HHV-8 ORF45 in Western Blotting applications (Zhu, F.X., et al. (2005). J Virol. 79(2):800-11; Sathish, N., et al. (2009). PLoS Pathog. 5(3):e1000332; De Leo, A., et al. (2017). PLoS Pathog. 13(8):e1006596).
Immunoprecipitation Analysis: A representative lot detected HHV-8 ORF45 in Immunoprecipitation applications (Sathish, N., et al. (2009). PLoS Pathog. 5(3):e1000332).
Immunocytochemistry Analysis: A representative lot detected HHV-8 ORF45 in Immunocytochemistry applications (Sathish, N., et al. (2009). PLoS Pathog. 5(3):e1000332).
Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Evaluated by Western Blotting in TPA-induced BCBL-1 cell lysates.
Western Blotting Analysis (WB): A 1:1,000 dilution of this antibody detected HHV-8 (Kaposi′s sarcoma-associated herpesvirus) ORF45 protein in lysates from 12-O-Tetradecanoylphorbol-13-acetate (TPA; 20 ng/mL; 5-7 days)-induced BCBL-1 cells.
Tested Applications
Western Blotting Analysis: A representative lot detected HHV-8 ORF45 in Western Blotting applications (Zhu, F.X., et al. (2005). J Virol. 79(2):800-11; Sathish, N., et al. (2009). PLoS Pathog. 5(3):e1000332; De Leo, A., et al. (2017). PLoS Pathog. 13(8):e1006596).
Immunoprecipitation Analysis: A representative lot detected HHV-8 ORF45 in Immunoprecipitation applications (Sathish, N., et al. (2009). PLoS Pathog. 5(3):e1000332).
Immunocytochemistry Analysis: A representative lot detected HHV-8 ORF45 in Immunocytochemistry applications (Sathish, N., et al. (2009). PLoS Pathog. 5(3):e1000332).
Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Anti-HHV-8 ORF45, clone ORF45, Cat. No. MABF2257, is a mouse monoclonal antibody that detects ORF45 in HHV-8 (Kaposi′s sarcoma-associated herpesvirus) and is tested for use in Immunocytochemistry, Immunoprecipitation, and Western Blotting.
Biochem/physiol Actions
Clone ORF45 is a mouse monoclonal antibody that detects ORF45 protein in HHV-8 (Kaposi′s sarcoma-associated herpesvirus).
Physical form
Purified mouse monoclonal antibody IgG1 in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
Preparation Note
Recommended storage: +2°C to +8°C.
Other Notes
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
未找到合适的产品?
试试我们的产品选型工具.
存储类别
12 - Non Combustible Liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持